Researchers in Cardiff University propose to investigate the long-term safety of Liothyronine (T3) using records from the late Dr G Skinner’s clinic. The study will use a data linkage approach that will enable researchers to analyse the patient data without knowing the identities of patients. Details of the study and, how patients can opt out of their data […]
If you’ve been diagnosed with TED and are seeking potential new treatment options, you might be interested in the LIDS clinical trial. The goal of this study is to investigate the effectiveness and safety of an oral study drug called Linsitinib, in adults with active, moderate-to-severe TED. You may be eligible if you: *Are over 18 years […]
Recently the CMA levied fines of £84 million to those companies that caused a price hike for liothyronine , causing untold distress for many thyroid patients. Dr Peter Taylor has created a Government Petition requesting that an amount equivalent to a proportion of the fine (1-5%) is made available for thyroid research and support for patients with hypothyroidism. […]
We have sadly learned of the death of Dr Barry Durrant-Peatfield. Dr Peatfield was a trustee of Thyroid UK in the early days and without him, Thyroid UK would not be where we are today. He was a very lovely, kind and generous man who truly cared about his patients and who, in our opinion, […]
© Thyroid UK 2022 a company limited by guarantee in England & Wales No. 6254073. Registered Office: Lufkins Farm, Great Bentley Road, Frating, Colchester CP7 7HN
Registered Charity Number: 1125270.
Charity Web Design by Step Internet
